Geron Corp. (GERN)
1.68
+0.03
(+1.82%)
USD |
NASDAQ |
Feb 27, 16:00
1.68
0.00 (0.00%)
After-Hours: 20:00
Geron Research and Development Expense (TTM) : 73.72M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | 914.12M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Plus Therapeutics, Inc. | 7.624M |